These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. ABCG1 is deficient in alveolar macrophages of GM-CSF knockout mice and patients with pulmonary alveolar proteinosis. Thomassen MJ; Barna BP; Malur AG; Bonfield TL; Farver CF; Malur A; Dalrymple H; Kavuru MS; Febbraio M J Lipid Res; 2007 Dec; 48(12):2762-8. PubMed ID: 17848583 [TBL] [Abstract][Full Text] [Related]
23. Pulmonary alveolar proteinosis: a bench-to-bedside story of granulocyte-macrophage colony-stimulating factor dysfunction. Greenhill SR; Kotton DN Chest; 2009 Aug; 136(2):571-577. PubMed ID: 19666756 [TBL] [Abstract][Full Text] [Related]
24. Pulmonary alveolar proteinosis - current and future therapeutical strategies. Jehn LB; Bonella F Curr Opin Pulm Med; 2023 Sep; 29(5):465-474. PubMed ID: 37395514 [TBL] [Abstract][Full Text] [Related]
25. Pulmonary Transplantation of Human Induced Pluripotent Stem Cell-derived Macrophages Ameliorates Pulmonary Alveolar Proteinosis. Happle C; Lachmann N; Ackermann M; Mirenska A; Göhring G; Thomay K; Mucci A; Hetzel M; Glomb T; Suzuki T; Chalk C; Glage S; Dittrich-Breiholz O; Trapnell B; Moritz T; Hansen G Am J Respir Crit Care Med; 2018 Aug; 198(3):350-360. PubMed ID: 29652170 [TBL] [Abstract][Full Text] [Related]
26. Detection of granulocyte-macrophage colony-stimulating factor in patients with pulmonary alveolar proteinosis. Carraway MS; Ghio AJ; Carter JD; Piantadosi CA Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1294-9. PubMed ID: 10764326 [TBL] [Abstract][Full Text] [Related]
27. Out of breath: GM-CSFRalpha mutations disrupt surfactant homeostasis. Notarangelo LD; Pessach I J Exp Med; 2008 Nov; 205(12):2693-7. PubMed ID: 19015311 [TBL] [Abstract][Full Text] [Related]
28. Pulmonary alveolar proteinosis caused by deletion of the GM-CSFRalpha gene in the X chromosome pseudoautosomal region 1. Martinez-Moczygemba M; Doan ML; Elidemir O; Fan LL; Cheung SW; Lei JT; Moore JP; Tavana G; Lewis LR; Zhu Y; Muzny DM; Gibbs RA; Huston DP J Exp Med; 2008 Nov; 205(12):2711-6. PubMed ID: 18955567 [TBL] [Abstract][Full Text] [Related]
29. Allogeneic Hematopoietic Stem Cell Transplantation After Prior Lung Transplantation for Hereditary Pulmonary Alveolar Proteinosis: A Case Report. Beeckmans H; Ambrocio GPL; Bos S; Vermaut A; Geudens V; Vanstapel A; Vanaudenaerde BM; De Baets F; Malfait TLA; Emonds MP; Van Raemdonck DE; Schoemans HM; Vos R Front Immunol; 2022; 13():931153. PubMed ID: 35928826 [TBL] [Abstract][Full Text] [Related]
30. Recurrence of pulmonary alveolar proteinosis after bilateral lung transplantation in a patient with a nonsense mutation in CSF2RB. Takaki M; Tanaka T; Komohara Y; Tsuchihashi Y; Mori D; Hayashi K; Fukuoka J; Yamasaki N; Nagayasu T; Ariyoshi K; Morimoto K; Nakata K Respir Med Case Rep; 2016; 19():89-93. PubMed ID: 27595063 [TBL] [Abstract][Full Text] [Related]
31. TALEN-mediated functional correction of human iPSC-derived macrophages in context of hereditary pulmonary alveolar proteinosis. Kuhn A; Ackermann M; Mussolino C; Cathomen T; Lachmann N; Moritz T Sci Rep; 2017 Nov; 7(1):15195. PubMed ID: 29123113 [TBL] [Abstract][Full Text] [Related]
32. Chronic pharmacological antagonism of the GM-CSF receptor in mice does not replicate the pulmonary alveolar proteinosis phenotype but does alter lung surfactant turnover. Corkill DJ; Hunt AN; Hinrichs MJ; White N; Rebelatto M; Roskos L; Nys J; Scott A; Robinson MJ; Ryan P; Postle AD; Sleeman MA Clin Sci (Lond); 2021 Nov; 135(22):2559-2573. PubMed ID: 34778899 [TBL] [Abstract][Full Text] [Related]
34. [Research progress of cell therapy in hereditary pulmonary alveolar proteinosis]. Zhang MN; Jin J; Song XY; Li SY Zhonghua Jie He He Hu Xi Za Zhi; 2023 Jul; 46(7):730-734. PubMed ID: 37402667 [TBL] [Abstract][Full Text] [Related]
35. Gm-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense. Trapnell BC; Whitsett JA Annu Rev Physiol; 2002; 64():775-802. PubMed ID: 11826288 [TBL] [Abstract][Full Text] [Related]
38. Pulmonary Alveolar Proteinosis Syndrome. Kelly A; McCarthy C Semin Respir Crit Care Med; 2020 Apr; 41(2):288-298. PubMed ID: 32279299 [TBL] [Abstract][Full Text] [Related]
39. Gene therapy of beta(c)-deficient pulmonary alveolar proteinosis (beta(c)-PAP): studies in a murine in vivo model. Kleff V; Sorg UR; Bury C; Suzuki T; Rattmann I; Jerabek-Willemsen M; Poremba C; Flasshove M; Opalka B; Trapnell B; Dirksen U; Moritz T Mol Ther; 2008 Apr; 16(4):757-64. PubMed ID: 18334984 [TBL] [Abstract][Full Text] [Related]
40. GM-CSF gene expression is normal but protein release is absent in a patient with pulmonary alveolar proteinosis. Tchou-Wong KM; Harkin TJ; Chi C; Bodkin M; Rom WN Am J Respir Crit Care Med; 1997 Dec; 156(6):1999-2002. PubMed ID: 9412586 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]